Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Background Diseases related to human papillomavirus (HPV) include warts, lesions, and cancers. ICL is idiopathic CD4 T cell lymphocytopenia. People with this rare disease get more HPV-related diseases than other people do. The diseases are more severe and harder to treat in people with ICL. Researchers want to see if …

Accepts healthy volunteers
  • 131 views
  • 04 Oct, 2022
  • 1 location
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Observer-blind, randomized, active-controlled prospective intervention study of Immunogenicity & Safety of SARS-Cov-2 Protein Subunit Recombinant Vaccine (Bio Farma) as a Booster Dose

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 2 locations
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula

intrauterine device (iud)
gardasil
Accepts healthy volunteers
lab tests
primary cancer
  • 85 views
  • 13 Mar, 2022
  • 1 location
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of 9-valent HPV recombinant vaccine in Chinese females aged 9 to 45 years

human papilloma virus vaccine
Accepts healthy volunteers
hpv vaccine
human papillomavirus
lab tests
  • 2 views
  • 07 Mar, 2022
  • 1 location
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of Quadrivalent HPV recombinant vaccine in Chinese females aged 9 to 26 years

hpv vaccine
recombinant vaccine
lab tests
Accepts healthy volunteers
  • 0 views
  • 10 Mar, 2022
  • 1 location
  • 0 views
  • 27 Oct, 2022